Annual Net Income
-$123.43 M
-$59.43 M-92.85%
31 December 2023
Summary:
Poseida Therapeutics annual net profit is currently -$123.43 million, with the most recent change of -$59.43 million (-92.85%) on 31 December 2023. During the last 3 years, it has risen by +$6.34 million (+4.89%). PSTX annual net income is now -527.76% below its all-time high of -$19.66 million, reached on 31 December 2017.PSTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$20.23 M
+$51.61 M+164.50%
30 September 2024
Summary:
Poseida Therapeutics quarterly net profit is currently $20.23 million, with the most recent change of +$51.61 million (+164.50%) on 30 September 2024. Over the past year, it has increased by +$52.01 million (+163.68%). PSTX quarterly net income is now -71.26% below its all-time high of $70.41 million, reached on 30 September 2022.PSTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$60.76 M
+$52.01 M+46.12%
30 September 2024
Summary:
Poseida Therapeutics TTM net profit is currently -$60.76 million, with the most recent change of +$52.01 million (+46.12%) on 30 September 2024. Over the past year, it has increased by +$70.64 million (+53.76%). PSTX TTM net income is now -355.67% below its all-time high of -$13.33 million, reached on 31 March 2019.PSTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.8% | +163.7% | +53.8% |
| 3 y3 years | +4.9% | +147.7% | +62.6% |
| 5 y5 years | -178.0% | +196.6% | +3.4% |
PSTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.8% | +4.9% | -71.3% | +134.8% | -108.0% | +62.6% |
| 5 y | 5 years | -178.0% | +4.9% | -71.3% | +134.8% | -108.0% | +62.6% |
| alltime | all time | -527.8% | +4.9% | -71.3% | +134.8% | -355.7% | +62.6% |
Poseida Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.23 M(-164.5%) | -$60.76 M(-46.1%) |
| June 2024 | - | -$31.37 M(+29.2%) | -$112.77 M(+3.6%) |
| Mar 2024 | - | -$24.27 M(-4.2%) | -$108.86 M(-11.8%) |
| Dec 2023 | -$123.43 M(+92.9%) | -$25.35 M(-20.2%) | -$123.43 M(-6.1%) |
| Sept 2023 | - | -$31.78 M(+15.7%) | -$131.40 M(+349.8%) |
| June 2023 | - | -$27.46 M(-29.3%) | -$29.21 M(-34.8%) |
| Mar 2023 | - | -$38.85 M(+16.6%) | -$44.79 M(-30.0%) |
| Dec 2022 | -$64.00 M(-48.8%) | -$33.32 M(-147.3%) | -$64.00 M(+119.1%) |
| Sept 2022 | - | $70.41 M(-263.6%) | -$29.21 M(-79.4%) |
| June 2022 | - | -$43.04 M(-25.9%) | -$142.05 M(-1.8%) |
| Mar 2022 | - | -$58.06 M(-4052.1%) | -$144.72 M(+15.8%) |
| Dec 2021 | -$124.97 M | $1.47 M(-103.5%) | -$124.97 M(-23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$42.42 M(-7.2%) | -$162.59 M(+5.2%) |
| June 2021 | - | -$45.70 M(+19.3%) | -$154.58 M(+11.0%) |
| Mar 2021 | - | -$38.31 M(+6.0%) | -$139.30 M(+7.3%) |
| Dec 2020 | -$129.78 M(+50.0%) | -$36.15 M(+5.0%) | -$129.77 M(+10.7%) |
| Sept 2020 | - | -$34.41 M(+13.1%) | -$117.24 M(+13.0%) |
| June 2020 | - | -$30.43 M(+5.7%) | -$103.78 M(+1.8%) |
| Mar 2020 | - | -$28.78 M(+21.9%) | -$101.98 M(+17.9%) |
| Dec 2019 | -$86.53 M(+94.9%) | -$23.61 M(+12.7%) | -$86.53 M(+37.5%) |
| Sept 2019 | - | -$20.95 M(-26.8%) | -$62.91 M(+49.9%) |
| June 2019 | - | -$28.63 M(+114.7%) | -$41.96 M(+214.7%) |
| Mar 2019 | - | -$13.33 M | -$13.33 M |
| Dec 2018 | -$44.40 M(+125.8%) | - | - |
| Dec 2017 | -$19.66 M | - | - |
FAQ
- What is Poseida Therapeutics annual net profit?
- What is the all time high annual net income for Poseida Therapeutics?
- What is Poseida Therapeutics annual net income year-on-year change?
- What is Poseida Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly net income year-on-year change?
- What is Poseida Therapeutics TTM net profit?
- What is the all time high TTM net income for Poseida Therapeutics?
- What is Poseida Therapeutics TTM net income year-on-year change?
What is Poseida Therapeutics annual net profit?
The current annual net income of PSTX is -$123.43 M
What is the all time high annual net income for Poseida Therapeutics?
Poseida Therapeutics all-time high annual net profit is -$19.66 M
What is Poseida Therapeutics annual net income year-on-year change?
Over the past year, PSTX annual net profit has changed by -$59.43 M (-92.85%)
What is Poseida Therapeutics quarterly net profit?
The current quarterly net income of PSTX is $20.23 M
What is the all time high quarterly net income for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly net profit is $70.41 M
What is Poseida Therapeutics quarterly net income year-on-year change?
Over the past year, PSTX quarterly net profit has changed by +$52.01 M (+163.68%)
What is Poseida Therapeutics TTM net profit?
The current TTM net income of PSTX is -$60.76 M
What is the all time high TTM net income for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM net profit is -$13.33 M
What is Poseida Therapeutics TTM net income year-on-year change?
Over the past year, PSTX TTM net profit has changed by +$70.64 M (+53.76%)